pHLIP®-mediated delivery of PEGylated liposomes to cancer cells
about
pH-triggered echogenicity and contents release from liposomes.Targeting breast tumors with pH (low) insertion peptidesSwitchable Lipids: Conformational Change for Fast pH-Triggered Cytoplasmic Delivery.Enhancement of radiation effect on cancer cells by gold-pHLIPThe pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesionspH-Triggered, Macromolecule-Sized Poration of Lipid Bilayers by Synthetically Evolved Peptides.Stimuli-responsive nanoparticles for targeting the tumor microenvironment.Advanced targeted nanomedicinePET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization StudyTargeting diseased tissues by pHLIP insertion at low cell surface pH.Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment.Novel nanoparticulate systems for lung cancer therapy: an updated review.Cationic switchable lipids: pH-triggered molecular switch for siRNA delivery.Noncanonical amino acids to improve the pH response of pHLIP insertion at tumor acidity.pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis.Stimuli-responsive liposomes for drug delivery.Applications of pHLIP Technology for Cancer Imaging and Therapy.Protonation-Driven Membrane Insertion of a pH-Low Insertion Peptide.pH-Dependent Cellular Internalization of Paramagnetic Nanoparticle.Testing the limits of rational design by engineering pH sensitivity into membrane-active peptides.Synthesis and characterization of pHLIP® coated gold nanoparticlespH-sensitive pHLIP® coated niosomes.Tumour acidosis: from the passenger to the driver's seat.E. coli Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy.Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.
P2860
Q30402045-56795E89-81D8-4643-B6C6-69DF1EDBB8F9Q34011123-3CD03094-D85A-4B9C-936E-410DABB3FB00Q34485756-4A3BF157-01F3-4445-9816-991ED3D49EAEQ35566912-104CAC28-03AF-455A-B8FD-07FA34C79F25Q35946329-C6D4BD33-FE1B-4426-A15E-AD88EA2F2F25Q36230180-A7C6FFE7-8434-4578-89C3-9128E773DCDEQ36307519-33B1DB9C-13E0-4633-BDFB-509545A3B574Q36388931-32241789-7D8D-413B-83F9-F305B7B9FFDBQ37278162-6211CDCB-4372-4C2D-8CA5-5FBAB3468096Q38198635-491916B9-3649-45CC-AFBA-C5EB1F33F326Q38274771-891FC06B-789D-4D58-A078-2D40AC113611Q38682486-5833A58F-6E1C-4149-ACCA-065B10112B13Q38685276-071C18CF-B5FE-4348-B745-B162FE62B0C9Q38762917-5540F048-C45A-4878-8291-2ECB4933470BQ38788622-8709BB86-3195-4077-956A-FD18C9AEBC4AQ38913096-EC325350-6B29-400F-80E1-ED56F7116A7CQ39041768-62F3ABED-FE72-4DA6-8FEB-522544DD4D4BQ39136162-8ED30C5B-DC8A-450D-BCAE-98DC8500843EQ39259251-8D2BA700-F983-4F63-965B-DDE951A9F66EQ39437463-43830FAB-F055-40A4-B917-0A296B6B2394Q40785813-A47A2E58-ED42-485F-A63A-F88ABC8D17B1Q41602806-FA82C089-EF1C-4CFE-B6AE-FCC6038BF8BFQ41682280-F1122C8F-819D-467E-B8EE-39262F033E58Q42623230-7D8F3508-40A3-4B4D-8E3C-2FF16B474EFAQ47772621-5A506CE9-A2F2-42A3-B84D-E9DA470CCADFQ52647653-83AD9CFE-A6C2-4617-91CA-E71F12127172Q52673229-BFFA392A-B94F-439A-835B-A56B111FDBBC
P2860
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells
@en
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells.
@nl
type
label
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells
@en
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells.
@nl
prefLabel
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells
@en
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells.
@nl
P2093
P2860
P1476
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells
@en
P2093
Dayanjali Wijesinghe
Jennifer Daniels
Oleg A Andreev
Yana K Reshetnyak
P2860
P304
P356
10.1016/J.JCONREL.2013.01.037
P407
P577
2013-02-15T00:00:00Z